DIAGNOS (DGNOF) News Today $0.19 0.00 (-0.21%) As of 04/4/2025 10:56 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period DIAGNOS Announces Amendment to Convertible DebenturesMarch 31, 2025 | globenewswire.comDIAGNOS is filing for the Saudi FDA Authorization of Its CARA SYSTEM, an AI Assisted Medical DeviceMarch 12, 2025 | globenewswire.comDIAGNOS Announces Amendment to Convertible DebenturesFebruary 28, 2025 | globenewswire.comDIAGNOS to File for FDA Pre-Market Authorization of Its AI-Powered CARA SYSTEM and Engages Ora as Regulatory SpecialistFebruary 25, 2025 | globenewswire.comCorrection - Diagnos Announces Closing of Private PlacementFebruary 14, 2025 | globenewswire.comDIAGNOS Closes $2 Million Private Placement to Boost AI Screening ServicesFebruary 5, 2025 | tipranks.comDIAGNOS Announces Closing of Private PlacementFebruary 5, 2025 | globenewswire.comDIAGNOS Announces Financial Contribution of $400,000 from the Government of CanadaJanuary 30, 2025 | globenewswire.comDIAGNOS to Present at The Microcap Conference 2025January 28, 2025 | globenewswire.comDIAGNOS Announces the Engagement of PromoterJanuary 13, 2025 | globenewswire.comOpen Thread: November 8, 2024November 8, 2024 | msn.comNorth Dakota woman shares her story about living with undiagnosed PCOS for yearsNovember 6, 2024 | msn.comNGMDF NuGen Medical Devices Inc.October 31, 2024 | seekingalpha.comDIAGNOS Announces Closing of Private PlacementOctober 25, 2024 | globenewswire.comDIAGNOS Announces the Engagement of Market Maker ConsultantOctober 17, 2024 | globenewswire.comTREIF Treatment.com AI Inc.October 16, 2024 | seekingalpha.comDIAGNOS Announces Grant of Stock OptionsOctober 3, 2024 | globenewswire.comDIAGNOS Announces Voting Results of Meeting of ShareholdersSeptember 26, 2024 | globenewswire.comDIAGNOS Announces Variation in One Insider OwnershipSeptember 23, 2024 | globenewswire.comDIAGNOS Announces Closing of Private PlacementSeptember 20, 2024 | globenewswire.comDIAGNOS Announces Date of Annual General and Special Meeting of ShareholdersAugust 22, 2024 | globenewswire.comDIAGNOS Successfully Completes ISO 13485 / MDSAP Audit and receives its certification to move forward with FDA and Health CanadaAugust 20, 2024 | globenewswire.comDIAGNOS Announces Closing of Second and Final Tranche of Private PlacementJune 5, 2024 | globenewswire.comDIAGNOS celebrates the launch of Labtician's new screening service for diabetic retinopathy in Ontario and renews its distribution agreementMay 21, 2024 | globenewswire.comDIAGNOS Announces Closing of First Tranche of Private PlacementMay 9, 2024 | globenewswire.comDIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024May 6, 2024 | globenewswire.comDIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certificationApril 16, 2024 | globenewswire.comDIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11thApril 9, 2024 | globenewswire.comDIAGNOS Announces Grant of Stock OptionsApril 3, 2024 | globenewswire.comDIAGNOS Welcomes Dr. Philippe Couillard to its Board of DirectorsApril 2, 2024 | globenewswire.comDIAGNOS Announces Closing of Second and Final Tranche of Private PlacementMarch 22, 2024 | globenewswire.comDIAGNOS Announces Grant of Stock OptionsMarch 4, 2024 | globenewswire.comDIAGNOS Welcomes Mr. Michael Braeuel to its Board of DirectorsFebruary 29, 2024 | globenewswire.comDIAGNOS Announces Closing of First Tranche of Private PlacementFebruary 27, 2024 | globenewswire.comDiagnos Announces Variation in One Insider Ownership of Common SharesFebruary 23, 2024 | globenewswire.comDIAGNOS recognized as a Top TSX Venture Exchange CompanyFebruary 21, 2024 | globenewswire.comBest of 2023December 8, 2023 | nytimes.com Remove Ads Get DIAGNOS News Delivered to You Automatically Sign up to receive the latest news and ratings for DGNOF and its competitors with MarketBeat's FREE daily newsletter. Email Address DGNOF Media Mentions By Week DGNOF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DGNOF News Sentiment▼0.000.69▲Average Business Services News Sentiment DGNOF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DGNOF Articles This Week▼10▲DGNOF Articles Average Week Remove Ads Get DIAGNOS News Delivered to You Automatically Sign up to receive the latest news and ratings for DGNOF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Orosur Mining News Surge Battery Metals News Blackstone Minerals News Nicox News Victory Square Technologies News FuelPositive News Poxel News Nextech3D.AI News Else Nutrition News Fobi AI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:DGNOF) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIAGNOS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DIAGNOS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DGNOF Stock Free DGNOF Stock Alerts